Advertisement

Abstract

Although clinicians recognise when a patient develops acute renal dysfunction, there is still no universally accepted definition; nor is there consensus on endpoints, which represent management success for clinical trials. It is therefore not surprising that it has been difficult to agree on guidelines for best renal management.

Keywords

Acute Renal Failure Renal Replacement Therapy Plasma Creatinine Base Deficit Dialysate Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thurau K, Boylan J (1976) Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 61:308–314PubMedCrossRefGoogle Scholar
  2. 2.
    Palazzo M (2001) Circulating volume and clinical assessment of the circulation. Br J Anaesth 86:743–746PubMedCrossRefGoogle Scholar
  3. 3.
    Shemesh O, Golbetz H, Kriss JP, Myers BD (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28(5):830–838PubMedCrossRefGoogle Scholar
  4. 4.
    Chagnac A, Kiberd BA, Farinas MC et al (1989) Outcome of the acute glomerular injury in proliferative lupus nephritis. J Clin Invest 84(3):922–930PubMedGoogle Scholar
  5. 5.
    Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41PubMedGoogle Scholar
  6. 6.
    Levey AS (1990) Measurement of renal function in chronic renal disease. Kidney Int 38(1):167–184PubMedCrossRefGoogle Scholar
  7. 7.
    Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470PubMedGoogle Scholar
  8. 8.
    Foundation NK (2002) K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–266Google Scholar
  9. 9.
    Bellomo R (2005) Defining, quantifying, and classifying acute renal failure. Crit Care Clin 21(2):223–237PubMedCrossRefGoogle Scholar
  10. 10.
    Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8(4):R204–212PubMedCrossRefGoogle Scholar
  11. 11.
    Rasmussen HH, Ibels LS (1982) Acute renal failure. Multivariate analysis of causes and risk factors. Am J Med 73(2):211–218PubMedCrossRefGoogle Scholar
  12. 12.
    Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50(3):811–818PubMedCrossRefGoogle Scholar
  13. 13.
    Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275(19):1489–1494PubMedCrossRefGoogle Scholar
  14. 14.
    Shusterman N, Strom BL, Murray TG et al (1987) Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 83(1):65–71PubMedCrossRefGoogle Scholar
  15. 15.
    Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units—causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24(2):192–198PubMedCrossRefGoogle Scholar
  16. 16.
    Hou SH, Bushinsky DA, Wish JB et al (1983) Hospital-acquired renal insufficiency: a prospective study. Am J Med 74(2):243–248PubMedCrossRefGoogle Scholar
  17. 17.
    Agmon Y, Peleg H, Greenfeld Z et al (1994) Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94(3):1069–1075PubMedCrossRefGoogle Scholar
  18. 18.
    Kramer P, Wigger W, Rieger J et al (1977) A rteriovenöse Hämofiltration: eine neue und einfache Methode zur Behandlung Diuretika-resistent überwasserter Patienten. Klin Wochenschr 55(22):1121–1122PubMedCrossRefGoogle Scholar
  19. 19.
    Schetz M (1999) Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 72:S88–S94PubMedCrossRefGoogle Scholar
  20. 20.
    Lowrie EG, Laird NM, Parker TF, Sargent JA (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305(20):1176–1181PubMedCrossRefGoogle Scholar
  21. 21.
    Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356(9223):26–30PubMedCrossRefGoogle Scholar
  22. 22.
    Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010–2019PubMedCrossRefGoogle Scholar
  23. 23.
    Davenport A, Davison AM, Will EJ (1993) Membrane biocompatibility: effects on cardiovascular stability in patients on hemofiltration. Kidney Int Suppl 41:S230–234PubMedGoogle Scholar
  24. 24.
    Gueugniaud PY, Bertin-Maghit M, Hirschauer C, Petit P (1994) Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 22(4):717PubMedCrossRefGoogle Scholar
  25. 25.
    Schiffl H, Lang SM, Konig A et al (1994) Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 344(8922):570–572PubMedCrossRefGoogle Scholar
  26. 26.
    Chong BH (2003) Heparin-induced thrombocytopenia. J Thromb Haemost 1(7):1471–1478PubMedCrossRefGoogle Scholar
  27. 27.
    Chong BH, Magnani HN (1992) Orgaran in heparin-induced thrombocytopenia. Haemostasis 22(2):85–91PubMedGoogle Scholar
  28. 28.
    Cole L, Bellomo R, Baldwin I et al (2003) The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Med 29(7):1113–1120PubMedCrossRefGoogle Scholar
  29. 29.
    Frankenfield DC, Reynolds HN, Wiles CE 3rd et al (1994) Urea removal during continuous hemodiafiltration. Crit Care Med 22(3):407–412PubMedCrossRefGoogle Scholar
  30. 30.
    Kelleher SP, Robinette JB, Miller F, Conger JD (1987) Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 31(3):725–730PubMedCrossRefGoogle Scholar
  31. 31.
    Solez K, Morel Maroger L, Sraer JD (1979) The morphology of “acute tubular necrosis” in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58(5):362–376PubMedCrossRefGoogle Scholar
  32. 32.
    van Bommel E, Bouvy ND, So KL et al (1995) Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 15(3):192–200PubMedGoogle Scholar
  33. 33.
    Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21(4):522–526PubMedCrossRefGoogle Scholar
  34. 34.
    Bellomo R, Tipping P, Boyce N (1995) Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 17(4):457–466PubMedCrossRefGoogle Scholar
  35. 35.
    Uchino S, Bellomo R, Goldsmith D et al (2002) Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28(5):651–655PubMedCrossRefGoogle Scholar
  36. 36.
    Cole L, Bellomo R, Hart G et al (2002) A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30(1):100–106PubMedCrossRefGoogle Scholar
  37. 37.
    Klouche K, Cavadore P, Portales P et al (2002) Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 15(2):150–157PubMedGoogle Scholar
  38. 38.
    Morgera S, Klonower D, Rocktaschel J et al (2003) TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transplant 18(7):1361–1369PubMedCrossRefGoogle Scholar
  39. 39.
    Morgera S, Haase M, Rocktaschel J et al (2003) Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 94(3):c75–80PubMedCrossRefGoogle Scholar
  40. 40.
    Morgera S, Haase M, Rocktaschel J et al (2003) High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 18(12):2570–2576PubMedCrossRefGoogle Scholar
  41. 41.
    Ziegler TR, Lazarus JM, Young LS et al (1991) Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 2(6):1130–1135PubMedGoogle Scholar
  42. 42.
    Fisher M, Grotta J (1993) New uses for calcium channel blockers. Therapeutic implications [published erratum appears in Drugs 1994 Feb;47(2):331]. Drugs 46(6):961–975PubMedGoogle Scholar
  43. 43.
    Bakir AA, Share DS, Levy PS et al (1996) Focal segmental glomerulosclerosis in adult African Americans. Clin Nephrol 46(5):306–311PubMedGoogle Scholar
  44. 44.
    Angus DC, Linde-Zwirble WT, Lidicker J et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310PubMedCrossRefGoogle Scholar
  45. 45.
    Vincent JL, de Mendonca A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800PubMedGoogle Scholar
  46. 46.
    Clermont G, Acker CG, Angus DC et al (2002) Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62(3):986–996PubMedCrossRefGoogle Scholar
  47. 47.
    Carbonell N, Blasco M, Ferreres J et al (2004) Sepsis and SOFA score: related outcome for critically ill renal patients. Clin Nephrol 62(3):185–192PubMedGoogle Scholar
  48. 48.
    de Mendonca A, Vincent JL, Suter PM et al (2000) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 26(7):915–921PubMedCrossRefGoogle Scholar
  49. 49.
    Metnitz PG, Krenn CG, Steltzer H et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30(9):2051–2058PubMedCrossRefGoogle Scholar
  50. 50.
    Chertow GM, Christiansen CL, Cleary PD et al (1995) Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 155(14):1505–1511PubMedCrossRefGoogle Scholar
  51. 51.
    Hamel MB, Phillips RS, Davis RB et al (1997) Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 127(3):195–202PubMedGoogle Scholar
  52. 52.
    Silvester W, Bellomo R, Cole L (2001) Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29(10):1910–1915PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • M. Palazzo
    • 1
  1. 1.Division Critical Care MedicineHammersmith Hospitals NHS Trust, Charing Cross HospitalLondonUK

Personalised recommendations